// App-Quantinova.ai

OC17.06 : Maternal cardiac function in women at high-risk for pre-eclampsia treated with 150mg aspirin or placebo: an observational study

Researchers

Presenter

  • H. Ling

Principal Investigators

  • P.G. Jara

  • A. Bisquera

  • L.C. Poon

  • K. Nicolaides

  • N. Kametas

Medical Centers

  • Fetal Medicine Research Institute, King's College Hospital, London, United Kingdom

  • Fetal Medicine Foundation, London, United Kingdom

  • NIHR Biomedical Research Centre, Guy's and St Thomas, King's College Hospital, London, United Kingdom

  • Obstetrics and Gynecology, Chinese University of Hong Kong, Hong Kong

Locations

  • United Kingdom

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Preeclampsia

Biomarkers

  • N/A

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Placebo Control

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved